Skip to content

Carnotim: what changed

BE 0407.016.255Other company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
€7,093
2024 · €6,435+€658
Equity
€1.0m
2024 · €1.0m+€7,093
Cash
€76,324
2024 · €26,480+€49,843
Balance sheet total
€1.0m
2024 · €1.0m+€5,604

Largest movements

2024 to 2025
Assets
  • Cash +€49,843

    up €49,843 (+188%), from €26,480 to €76,324

    mainly Receivables within one year (+€37,230) and Net result for the year (+€7,093)

  • Receivables within one year -€37,230

    down €37,230 (-6.0%), from €617,271 to €580,040

Equity and liabilities

No liability line moved by more than 1% of the balance sheet total.

    Income statement
    • Taxes -€76,577

      down €76,577 (-97.0%), from €78,953 to €2,376

    • Gross operating margin +€1,453

      up €1,453 (+37.8%), from -€3,846 to -€2,393

    • Financial income -€173

      down €173 (-1.4%), from €12,257 to €12,084

    Change in the result, 2024 to 2025

    effect on the result

    For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

    Result 2024 €6,435
    Gross operating margin +€1,453
    Other operating charges -€4
    Financial income -€173
    Financial charges +€18
    Taxes +€76,577
    Deferred taxes and other -€77,212
    Result 2025 €7,093
    raises the resultlowers the resultnot broken down further in the accounts

    Derived cash bridge

    cash 2024 to 2025

    The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

    From operations +€49,843
    Investment €0
    Financing €0
    Cash 2024 €26,480
    Net result for the year +€7,093
    Receivables after one year +€7,009
    Receivables within one year +€37,230
    Trade debts -€522
    Other debts -€968
    Cash 2025 €76,324
    brings cash intakes cash out
    Every line side by side 34 lines
    Line Code 2024 2025 Change %
    Total assets 20/58 €1,026,584 €1,032,187 +€5,604 +0.5%
    Current assets 29/58 €1,026,584 €1,032,187 +€5,604 +0.5%
    Amounts receivable after more than one year 29 €382,833 €375,824 -€7,009 -1.8%
    Other amounts receivable 291 €382,833 €375,824 -€7,009 -1.8%
    Amounts receivable within one year 40/41 €617,271 €580,040 -€37,230 -6.0%
    Other amounts receivable 41 €617,271 €580,040 -€37,230 -6.0%
    Cash at bank and in hand 54/58 €26,480 €76,324 +€49,843 +188%
    Total equity and liabilities 10/49 €1,026,584 €1,032,187 +€5,604 +0.5%
    Equity 10/15 €1,024,865 €1,031,958 +€7,093 +0.7%
    Contributions 10/11 €247,894 €247,894 = 0.0%
    Capital 10 €247,894 €247,894 = 0.0%
    Issued capital 100 €247,894 €247,894 = 0.0%
    Reserves 13 €776,971 €784,065 +€7,093 +0.9%
    Non-distributable reserves 130/1 €24,789 €24,789 = 0.0%
    Legal reserve 130 €24,789 €24,789 = 0.0%
    Distributable reserves 133 €752,182 €759,275 +€7,093 +0.9%
    Amounts payable 17/49 €1,719 €229 -€1,490 -86.7%
    Amounts payable within one year 42/48 €1,719 €229 -€1,490 -86.7%
    Trade debts 44 €751 €229 -€522 -69.5%
    Suppliers 440/4 €751 €229 -€522 -69.5%
    Other amounts payable 47/48 €968 - -€968
    Other operating charges 640/8 €182 €186 +€4 +2.1%
    Gross operating margin 9900 -€3,846 -€2,393 +€1,453 +37.8%
    Operating profit (loss) 9901 -€4,027 -€2,579 +€1,449 +36.0%
    Financial income 75/76B €12,257 €12,084 -€173 -1.4%
    Recurring financial income 75 €12,257 €12,084 -€173 -1.4%
    Financial charges 65/66B €54 €36 -€18 -33.1%
    Recurring financial charges 65 €54 €36 -€18 -33.1%
    Profit (loss) for the period before taxes 9903 €8,176 €9,469 +€1,293 +15.8%
    Transfer from deferred taxes 780 €77,212 - -€77,212
    Income taxes 67/77 €78,953 €2,376 -€76,577 -97.0%
    Profit (loss) for the period 9904 €6,435 €7,093 +€658 +10.2%
    Transfer from tax-exempt reserves 789 €231,636 - -€231,636
    Profit (loss) for the period to be appropriated 9905 €238,071 €7,093 -€230,977 -97.0%

    Value

    latest balance sheet 31-12-2025 · indication, not a valuation or advice

    Indicative value of the equity

    Indication, not a valuation or advice
    €535,126 to €542,784

    Midpoint €538,317 · 50% capitalised earnings, 50% adjusted equity

    Capitalisation rate 12% result over 3 years earnings weight 50%

    Worked out with Checked's starting values, not your estimate and not market data. Change the assumptions: the value follows.

    Adjusted equity €1.0m
    Capitalised earnings €38,293 to €53,610
    Indication €535,126 to €542,784

    Adjusted equity

    balance sheet 31-12-2025
    Equity (10/15)
    €1,031,958
    Revaluation of assets
    €0
    Deferred tax on the revaluation
    €0
    Other adjustment
    €0
    Adjusted equity
    €1.0m

    Capitalised earnings

    net result for the year (9904)
    2025
    €7,093
    2024
    €6,435
    2023
    €2,554
    2022
    -€1,498
    2021
    -€2,576
    Average result
    €5,361
    Divided by the capitalisation rate
    14% / 12% / 10%
    Capitalised earnings
    €38,293 / €44,675 / €53,610

    Limits of the indication

    • Checked holds no market prices or comparable transactions.
    • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
    • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
    • The result is not corrected for the manager's pay. If the company pays less or more than a market salary, the capitalised earnings are too high or too low.
    • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

    For a valuation to base a decision on, go to a company auditor or a certified accountant.

    Calculation and sources

    Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 20 November 2026 via checked.be.